[1]
|
Kroemer, G. and Pouyssegur, J. (2008) Tumor Cell Metabolism: Cancer’s Achilles’ Heel. Cancer Cell, 13, 472-482. https://doi.org/10.1016/j.ccr.2008.05.005
|
[2]
|
Li., Z. and Zhang, H. (2016) Reprogramming of Glucose, Fatty Acid and Amino Acid Metabolism for Cancer Progression. Cellular and Molecular Life Sciences, 73, 377-392. https://doi.org/10.1007/s00018-015-2070-4
|
[3]
|
段泽琳. 靶向SLC1A5介导的谷氨酰胺摄取作为肿瘤抗增殖新途径[D]: [硕士学位论文]. 苏州: 苏州大学, 2021.
|
[4]
|
Luengo, A., Cui, D.Y. and Vander Heidfn, M.G. (2017) Targeling Me-Metabolism for Cancer Therapy. Cell Chemical Biology, 24, 1161-1180. https://doi.org/10.1016/j.chembiol.2017.08.028
|
[5]
|
Brandon, F., Ashley, S. and Deberardinis, R.J. (2020) Metabolic Reprogramming and Cancer Progression. Science, 368, eaaw54. https://doi.org/10.1126/science.aaw5473
|
[6]
|
张峥, 秦立强. 氨基酸及其转运体对肿瘤细胞和T细胞作用的研究进展[J]. 肿瘤代谢与营养电子杂志, 2022, 9(3): 271-275.
|
[7]
|
王林琳, 孙振亮. 氨基酸转运体在肿瘤代谢中的研究进展[J]. 生物技术进展, 2022, 12(1): 50-56.
|
[8]
|
Yahyaoui, R. and Pérez-Frías, J. (2019) Amino Acid Transport Defects in Human Inherited Metabolic Disorders. International Journal of Molecular Sciences, 21, Article 119. https://doi.org/10.3390/ijms21010119
|
[9]
|
Bai, X., Moraes, T.F. and Reithmeier, R.A.F. (2017) Structural Biology of Solute Carrier (SLC) Membrane Transport Proteins. Molecular Membrane Biology, 34, 1-32. https://doi.org/10.1080/09687688.2018.1448123
|
[10]
|
陆心月, 郑旭, 王志钢, 吴晓彤. 哺乳动物细胞氨基酸转运体及胞内感受机制研究进展[J]. 生命科学, 2022, 34(9): 1155-1167.
|
[11]
|
Xiong, J. and Zhao, W.L. (2023) A Novel SLC1A1-RIC1 Fusion Sensitive to Asparaginase-Based Therapy in Natural Killer/T-Cell Lymphoma. British Journal of Haematology, 203, 485-489. https://doi.org/10.1111/bjh.19066
|
[12]
|
Wang, X., Chen, Z., Xu, J., et al. (2022) SLC1A1-Mediated Cellular and Mitochondrial Influx of R-2-Hydroxyglutarate in Vascular Endothelial Cells Promotes Tumor Angiogenesis in IDH1-Mutant Solid Tumors. Cell Research, 32, 638-658. https://doi.org/10.1038/s41422-022-00650-w
|
[13]
|
Yang, Z., Su, W., Wei, X., Qu, S., Zhao, D., Zhou, J., Wang, Y., Guan, Q., Qin, C., Xiang, J., Zen, K. and Yao, B. (2023) HIF-1α Drives Resistance to Ferroptosis in Solid Tumors by Promoting Lactate Production and Activating SLC1A1. Cell Reports, 42, Article ID: 112945. https://doi.org/10.1016/j.celrep.2023.112945
|
[14]
|
Guo, W., Li, K., Sun, B., Xu, D., Tong, L., Yin, H., Liao, Y., Song, H., Wang, T., Jing, B., et al. (2021) Dysregulated Glutamate Transporter SLC1A1 Propels Cystine Uptake Via Xc− for Glutathione Synthesis in Lung Cancer. Cancer Research, 81, 552-566. https://doi.org/10.1158/0008-5472.CAN-20-0617
|
[15]
|
Lewerenz, J., Hewett, S.J., Huang, Y., Lambros, M., Gout, P.W., Kalivas, P.W., et al. (2013) The Cystine/Glutamate Antiporter System XC− in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities. Antioxidants & Redox Signaling, 18, 522-555. https://doi.org/10.1089/ars.2011.4391
|
[16]
|
Lo, M., Wang, Y.Z. and Gout, P.W. (2008) The XC− Cystine/Glutamate Antiporter: A Potential Target for Therapy of Cancer and Other Diseases. Journal of Cellular Physiology, 215, 593-602. https://doi.org/10.1002/jcp.21366
|
[17]
|
Bailey, C.G., Ryan, R.M., Thoeng, A.D., Ng, C., King, K. and Vanslambrouck, J.M. (2011) Loss-of-Function Mutations in the Glutamate Transporter SLC1A1 Cause Human Dicarboxylic Aminoaciduria. Journal of Clinical Investigation, 121, 446-453. https://doi.org/10.1172/JCI44474
|
[18]
|
Pavlova, N.N., Hui, S., Ghergurovich, J.M., et al. (2018) As Extracellular Glutamine Levels Decline, Asparagine Becomes an Essential Amino Acid. Cell Metabolism, 27, 428-438. https://doi.org/10.1016/j.cmet.2017.12.006
|
[19]
|
Xiong, J., Wang, N., Zhong, H., et al. (2021) SLC1A1 Mediated Glutamine Addiction and Contributed to Natural Killer T-Cell Lymphoma Progression with Immunotherapeutic Potential. eBioMedicine, 72, Article ID: 103614. https://doi.org/10.1016/j.ebiom.2021.103614
|
[20]
|
Dang, L., et al. (2009) Cancer-Associated IDH1 Mutations Produce 2-Hydroxyglutarate. Nature, 462, 739-744. https://doi.org/10.1038/nature08617
|
[21]
|
Castaldo, P., et al. (2009) Role of The Mitochondrial Sodium/Calcium Exchanger in Neuronal Physiology and in the Pathogenesis of Neurological Diseases. Progress in Neurobiology, 87, 58-79. https://doi.org/10.1016/j.pneurobio.2008.09.017
|
[22]
|
Yuan, S., Wei, C., Liu, G., Zhang, L., Li, J., Li, L., Cai, S. and Fang, L. (2022) Sorafenib Attenuates Liver Fibrosis by Triggering Hepatic Stellate Cell Ferroptosis via HIF-1α/SLC7A11 Pathway. Cell Proliferation, 55, e13158. https://doi.org/10.1111/cpr.13158
|
[23]
|
Zhao, Y., Li, M., Yao, X., Fei, Y., Lin, Z., Li, Z., Cai, K., Zhao, Y. and Luo, Z. (2020) HCAR1/MCT1 Regulates Tumor Ferroptosis through the Lactate-Mediated AMPK-SCD1 Activity and Its Therapeutic Implications. Cell Reports, 33, Article ID: 108487. https://doi.org/10.1016/j.celrep.2020.108487
|
[24]
|
Hagiwara, T., Tanaka, K., Takai, S., Maeno-Hikichi, Y., Mukainaka, Y. and Wada, K., (1996) Genomic Organization, Promoter Analysis, and Chromosomal Localization of the Gene for the Mouse Glial High-Affinity Glutamate Transporter Slc1a3. Genomics, 33, 508-515. https://doi.org/10.1006/geno.1996.0226
|
[25]
|
Mamoor, S. (2020) SLC1A3 (EAAT1) Is Over-Expressed in Brain Metastatic Breast Cancer. https://doi.org/10.31219/osf.io/6qnfe
|
[26]
|
Ganapathy, V., Thangaraju, M. and Prasad, P.D. (2009) Nutrient Transporters in Cancer: Relevance to Warburg Hypothesis and beyond. Pharmacology & Therapeutics, 121, 29-40. https://doi.org/10.1016/j.pharmthera.2008.09.005
|
[27]
|
Rathmell, J.C., Fox, C.J., Plas, D.R., et al. (2003) Akt-Directed Glucose Metab-Olism Can Prevent Bax Conformation Change and Promote Growth Factor-Independent Survival. Molecular and Cellular Biology, 23, 7315-7328. https://doi.org/10.1128/MCB.23.20.7315-7328.2003
|
[28]
|
Zhou, Q.L., Jiang, Z.Y., Holik, J., et al. (2008) Akt Substrate TBC1D1 Regulates GLUT1 Expression through the MTOR Pathway in 3T3-L1 Adipo-Cytes. Biochemical Journal, 411, 647-655. https://doi.org/10.1042/BJ20071084
|
[29]
|
Lien, E.C., Lyssiotis, C.A. and Cantley, L.C. (2016) Metabolic Reprogramming by the PI3K-Akt-MTOR Pathway in Cancer. In: Cramer, T.A. and Schmitt, C., Eds., Metabolism in Cancer, Springer, Cham, 39-72. https://doi.org/10.1007/978-3-319-42118-6_3
|
[30]
|
Tajan, M., Hock, A.K., Blagih, J., et al. (2018) A Role for P53 in the Adaptation to Glutamine Starvation through the Expression of SLC1A3. Cell Metabolism, 28, 721-736.E6. https://doi.org/10.1016/j.cmet.2018.07.005
|
[31]
|
Cong, W., Wang, Z.L., Liu, W. and Ai, Z.L. (2019) CD133 Promotes the Self-Renewal Capacity of Thyroid Cancer Stem Cells through Activation of Glutamate Aspartate Transporter SLC1A3 Expression. Biochemical and Biophysical Research Communications, 511, 87-91. https://doi.org/10.1016/j.bbrc.2019.02.023
|
[32]
|
Tong, H., Yu, X., Lu, X. and Wang, P. (2015) Downregulation of Solute Carriers of Glutamate in Gliosomes and Synaptosomes May Explain Local Brain Metastasis in Anaplastic Glioblastoma. IUBMB Life, 67, 306-311. https://doi.org/10.1002/iub.1372
|
[33]
|
Walczak, K., Deneka-Hannemann, S., Jarosz, B., Zgrajka, W., Stoma, F., et al. (2014) Kynurenic Acid Inhibits Proliferation and Migration of Human Glioblas-Toma T98G Cells. Pharmacological Reports, 66, 130-136. https://doi.org/10.1016/j.pharep.2013.06.007
|
[34]
|
Ye, Z.C., Rothstein, J.D. and Sontheimer, H. (1999) Compromised Glutamatetransport in Human Glioma Cells: Reduction-Mislocalization of Sodium-Dependent Glutamate Transporter S and Enhanced Activity of Cystine-Glutamate Exchange. Journal of Neuroscience, 19, 10767-10777. https://doi.org/10.1523/JNEUROSCI.19-24-10767.1999
|
[35]
|
Lyons, S.A., Chung, W.J., Weaver, A.K., Ogunrinu, T., and Sontheimer, H. (2007) Autocrine Glutamate Signaling Promotes Glioma Cell Invasion. Cancer Research, 67, 9463-9471. https://doi.org/10.1158/0008-5472.CAN-07-2034
|
[36]
|
VanLith, S.A., Navis, A.C., Verrijp, K., Niclou, S.P., Bjerkvig, R., et al. (2014) Glutamate as Chemotactic Fuel for Diffuse Glioma Cells: Are They Glutamate Suckers? Biochimica et Biophysica Acta (BBA)—Reviews on Cancer, 1846, 66-74. https://doi.org/10.1016/j.bbcan.2014.04.004
|
[37]
|
Hofmann, K., Maria, D., Fink, T., et al. (1994) Human Neutral Amino Acid Transporter ASCT1: Structure of the Gene (SLC1A4) and Localization to Chromosome 2p13-P15. Genomics, 24, 20-26. https://doi.org/10.1006/geno.1994.1577
|
[38]
|
Sedláková, L., Lauthová, P., Těrbová, K., et al. (2021) Severe Neurodevelopmental Disorder with Intractable Seizures Due to a Novel SLC1A4 Homozygous Variant. European Journal of Medical Genetics, 64, Article ID: 104263. https://doi.org/10.1016/j.ejmg.2021.104263
|
[39]
|
Liu, Y., Xiong, H., Yan, C., Wang, Y., Cao, W. and Qie, S. (2023) Bioinformatic Analysis of the Prognostic Value of a Panel of Six Amino Acid Transporters in Human Cancers. Cell Journal, 25, 613-624.
|
[40]
|
Palumbo, P., Petracca, A., Maggi, R., et al. (2019) A Novel Dominant-Negative FGFR1 Variant Causes Hartsfield Syndrome by Deregulating RAS/ERK1/2 Pathway. European Journal of Human Genetics, 27, 1113-1120. https://doi.org/10.1038/s41431-019-0350-4
|
[41]
|
Wolosker, H. and Radzishevsky, I. (2013) The Serine Shuttle between Glia and Neurons: Implications for Neurotransmission and Neurodegeneration. Biochemical Society Transactions, 41, 1546-1550. https://doi.org/10.1042/BST20130220
|
[42]
|
Eitan, K., Salman, Z., Inna, R., et al. (2018) ASCT1 (Slc1a4) Transporter Is a Physiologic Regulator of Brain D-Serine and Neurodevelopment. Proceedings of the National Academy of Sciences of the United States of America, 115, 9628-9633. https://doi.org/10.1073/pnas.1722677115
|
[43]
|
Wang, X.C., He, Q.F., Shen, H.Y., Xia, A.L., Tian, W.F., Yu, W.W. and Sun, B.C. (2019) TOX Promotes the Exhaustion of Antitumor CD8 T Cells by Preventing PD1 Degradation in Hepatocellular Carcinoma. Journal of Hepatology, 71, 731-741. https://doi.org/10.1016/j.jhep.2019.05.015
|
[44]
|
Peng, X., Chen, R., Cai, S., et al. (2021) SLC1A4: A Powerful Prognostic Marker and Promising Therapeutic Target for HCC. Frontiers in Oncology, 11, Article 650355. https://doi.org/10.3389/fonc.2021.650355
|
[45]
|
Parker, S.J., Amendola, C.R., Hollinshead, K.E.R., et al. (2020) Selective Alanine Transporter Utilization Creates a Targetable Metabolic Niche in Pancreatic Cancer. Cancer Discovery, 10, 1018-1037. https://doi.org/10.1158/2159-8290.CD-19-0959
|
[46]
|
Wong, C.H., Li, C.H., He, Q., et al. (2019) Ectopic HOTTIP Expression Induces Non-Canonical Transactivation Pathways to Promote Growth and Invasiveness in Pancreatic Ductal Aden Ocarcinoma. Cold Spring Harbor Laboratory. https://doi.org/10.1101/812800
|
[47]
|
Bi, X. and Henry, C.J. (2017) Plasma-Free Amino Acid Profiles Are Predictors of Cancer and Diabetes Development. Nutrition & Diabetes, 7, e249. https://doi.org/10.1038/nutd.2016.55
|
[48]
|
陆健, 龚镭, 王小云, 等. 氨基酸转运载体SLC1A5在胃癌组织中的表达及其临床病理学意义[J]. 现代生物医学进展, 2019, 19(20): 3880-3885. https://doi.org/10.13241/j.cnki.pmb.2019.20.018
|
[49]
|
Jiang, H., Zhang, N., Tang, T., et al. (2020) Target the Human Alanine/Serine/Cysteine Transporter 2(ASCT2): Achievement and Future for Novel Cancer Therapy. Pharmacological Research, 158, Article ID: 104844. https://doi.org/10.1016/j.phrs.2020.104844
|
[50]
|
Bott, A.J., Shen, J., Tonelli, C., et al. (2019) Glutamine Anabolism Plays a Critical Role in Pancreatic Cancer by Coupling Carbon and Nitrogen Metabolism. Cell Reports, 29, 1287-1298.E6. https://doi.org/10.1016/j.celrep.2019.09.056
|
[51]
|
Li, L., Meng, Y., Li, Z., et al. (2019) Discovery and Development of Small Molecule Modulators Targeting Glutamine Metabolism. European Journal of Medicinal Chemistry, 163, 215-242. https://doi.org/10.1016/j.ejmech.2018.11.066
|
[52]
|
Zou, Z., Tao, T., Li, H., et al. (2020) MTOR Signaling Pathway and MTOR Inhibitors in Cancer: Progress and Challenges. Cell and Bioscience, 10, Article No. 31. https://doi.org/10.1186/s13578-020-00396-1
|
[53]
|
Sanein, J.Q., Hoeksema, M.D., et al. (2015) Targeting SLC1a5-Mediated Glutamine Dependence in Non-Small Cell Lung Cancer. International Journal of Cancer, 137, 1587-1597.
|
[54]
|
Avissar, N.E., Sax, H.C. and Toia, L. (2008) In Human Entrocytes, GLN Transport and ASCT2 Surface Expression Induced by Short-Term EGF Are MAPK, PI3K, and Rho-Dependent. Digestive Diseases and Sciences, 53, 2113-2125. https://doi.org/10.1007/s10620-007-0120-y
|